. Author manuscript; available in PMC: 2020 Apr 28.

Published in final edited form as: Liver Transpl. 2019 Jan;25(1):14–24. doi: 10.1002/lt.25346

Table 3:

Characteristics of patients with and without frailty

	Frail	Non-frail	p-value
NASH	(n=51)	(n=54)
Age in years, mean (SD)	60.1 (7.2)	58.9 (8.8)	0.64
Male (%)	28 (54.9)	23 (42.6)	0.21
BMI (Kg/m²), mean (SD)	36.0 (8.3)	33.8 (8.8)	0.21
MELD, mean (SD)	16.8 (7.3)	14.6 (5.6)	0.18
Decompensation pre-LT (%)
Hepatic encephalopathy	40 (78.4)	37 (68.5)	0.25
Ascites	43 (84.3)	42 (77.8)	0.39
Variceal bleeding	11 (21.6)	19 (35.2)	0.12
Hepatorenal syndrome	8 (15.7)	4 (7.4)	0.18
Sarcopenia (%)	9 (18.4)	14 (25.9)	0.36
Myosteatosis (%)	33 (67.3)	38 (70.4)	0.74
Hospitalization pre-LT (%)	28 (54.9)	22 (40.7)	0.15
LOS (days), mean (SD)	13.3 (12.6)	8.9 (7.4)	0.36
Delisted 1-year cumulative incidence (% [95% CI])	14.6% [4.7, 23.4]	13.2% [4.2, 21.3]	0.23^†
Death 1-year cumulative incidence (% [95% CI])	7.3% [0.1, 13.9]	11.5% [3.1, 19.2]	0.83^†
ALD	(n=37)	(n=73)
Age in years, mean (SD)	55.2 (8.5)	52.0 (10.6)	0.12
Male (%)	27 (73.0)	46 (63.0)	0.30
BMI (Kg/m²) (%)	28.3 (5.0)	27.2 (5.0)	0.20
MELD, mean (SD)	17.8 (5.8)	18.7 (6.4)	0.63
Decompensation pre-LT (%)
Hepatic encephalopathy	29 (78.4)	52 (71.2)	0.42
Ascites	36 (97.3)	68 (93.2)	0.37
Variceal bleeding	12 (32.4)	26 (35.6)	0.74
Hepatorenal syndrome	3 (8.1)	6 (8.2)	0.98
Sarcopenia (%)	15 (41.7)	34 (46.6)	0.63
Myosteatosis (%)	20 (55.6)	41 (56.2)	0.95
Hospitalization pre-LT (%)	26 (70.3)	46 (63.0)	0.45
LOS (days), mean (SD)	14.8 (16.8)	12.6 (11.0)	0.66
Delisted 1-year cumulative incidence (% [95% CI])	34.6% [16.6, 48.7]	27.1% [15.9, 36.8]	0.46^†
Death 1-year cumulative incidence (% [95% CI])	22.9% [7.6, 35.7]	21.4% [11.2, 30.4]	0.93^†

^†

p-value from a Cox-proportional hazards model; LOS- length of stay